Dr. David Brian Hom, MD

Dr. Hom practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Hom's NPI, 1659305027, was assigned on July 10, 2006. Dr. Hom graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Hom holds California license G50542.

Dr. Hom's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Hom's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Hom is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hom practices. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Hom's primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Hom is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Hom's licenses on file in 6 states: California, Montana, Ohio, Minnesota, Michigan and Alabama.

Dmand AI lists chronic sinusitis, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and tinnitus among the conditions Dr. Hom treats.

CMS data shows 212 Medicare services from Dr. Hom across 8 procedure codes in 2024, for 148 Medicare patients. Medicare paid $20,005 for them.

CMS counts 148 Medicare patients who saw Dr. Hom in 2024. The largest group is 65 to 74, with 66 patients. 61% of them have high blood pressure, and 61% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hom's median patient age at 56, with 49% women.

In 2024, Dr. Hom wrote 47 Medicare Part D claims for 27 patients. 94% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $188 in total drug cost. In 2023, CMS named 67 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hom for performance year 2024, reported as part of a group. Dr. Hom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hom as offering telehealth. CMS counts 54 procedures of melanoma (skin cancer) excision by Dr. Hom, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 62 papers to Dr. Hom, published from 2012 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Wound Healing, Surgical Flaps and Skin. Dr. Hom has published most often in Laryngoscope. Dr. Hom's most frequent co-authors are Kevin James Little, MD, Farhoud Faraji, MD, PhD and Eric Alan Gantwerker, MD.

CMS Open Payments shows 41 general payments to Dr. Hom from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Medical Device Business Services, Inc. paid the most, $8,750.

Dmand AI lists 13 awards for Dr. Hom, most recently America's Top Doctors in 2023.

Dr. Hom graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Hom is a member of AAFPRS, NHS and ACS.

Dr. Hom is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.